Mefenamic Acid
Active substance: mefenamic acid
CAPSULE · MEFENAMIC ACID 250 mg/1
United StatesActive
Marketing holder: Lupin Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- MEFENAMIC ACID · 250 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-298d-7ea8-adfb-9807c3e71a13,01a1208d-170e-731f-974b-76f3fd2f8b9a,01a1208d-6a4d-7ac1-8f6c-af1799895707,01a1208d-8c6e-7c57-bcb0-5e2a4e1d68f4,01a12092-d6f4-72a2-aa47-12f0f797260d;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 68180-185
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 68180-185 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68180-185 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68180-185 · Verified 2026-10-09 · open in source